Skip to main content

Amgen Product sales

  • AMGN · Nasdaq
  • Biotechnology
  • S&P 500
$465.67−0.30%Close 13 Nov 2026 · Market value $253.3B

Product sales at Amgen came to $9.9B for the quarter to 30 Sep 2026, up 8.2% from a year earlier.

As Amgen reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$7.8BDec 2023$7.1BMar 2024$8.0BJun 2024$8.2BSep 2024$8.7BDec 2024$7.9BMar 2025$8.8BJun 2025$9.1BSep 2025$9.4BDec 2025$8.2BMar 2026$9.5BJun 2026$9.9BSep 2026
Amgen Product sales, every reported period
Period endingProduct salesChange on a yearFiled
30 Sep 2026$9.9Bup 8.2%4 Nov 2026
30 Jun 2026$9.5Bup 8.7%5 Aug 2026
31 Mar 2026$8.2Bup 4.4%1 May 2026
31 Dec 2025$9.4Bup 7.5%13 Feb 2026
30 Sep 2025$9.1Bup 12.1%5 Nov 2025
30 Jun 2025$8.8Bup 9.1%6 Aug 2025
31 Mar 2025$7.9Bup 10.6%2 May 2025
31 Dec 2024$8.7Bup 11.3%14 Feb 2025
30 Sep 2024$8.2Bup 24.5%31 Oct 2024
30 Jun 2024$8.0Bup 20.3%7 Aug 2024
31 Mar 2024$7.1Bup 21.8%3 May 2024
31 Dec 2023$7.8Bup 19.6%14 Feb 2024
30 Sep 2023$6.5Bup 5.0%31 Oct 2023
30 Jun 2023$6.7Bup 6.4%4 Aug 2023
31 Mar 2023$5.8Bup 2.0%28 Apr 2023
31 Dec 2022$6.6Bup 4.5%9 Feb 2023
30 Sep 2022$6.2Bdown 1.3%4 Nov 2022
30 Jun 2022$6.3Bup 2.7%5 Aug 2022
31 Mar 2022$5.7Bup 2.5%28 Apr 2022
31 Dec 2021$6.3Bdown 1.0%16 Feb 2022
30 Sep 2021$6.3Bup 3.5%3 Nov 2021
30 Jun 2021$6.1Bup 3.5%4 Aug 2021
31 Mar 2021$5.6Bdown 5.1%28 Apr 2021
31 Dec 2020$6.3Bup 7.7%9 Feb 2021
30 Sep 2020$6.1Bup 11.7%29 Oct 2020
30 Jun 2020$5.9Bup 6.0%29 Jul 2020
31 Mar 2020$5.9Bup 11.5%1 May 2020
31 Dec 2019$5.9Bdown 2.0%12 Feb 2020
30 Sep 2019$5.5Bdown 0.9%30 Oct 2019
30 Jun 2019$5.6Bdown 1.8%31 Jul 2019
31 Mar 2019$5.3Bdown 1.1%1 May 2019
31 Dec 2018$6.0Bup 7.8%13 Feb 2019
30 Sep 2018$5.5Bup 1.0%31 Oct 2018
30 Jun 2018$5.7Bup 1.9%27 Jul 2018
31 Mar 2018$5.3Bup 2.8%25 Apr 2018
31 Dec 2017$5.6B—13 Feb 2018
30 Sep 2017$5.5B—26 Oct 2017
30 Jun 2017$5.6B—26 Jul 2017
31 Mar 2017$5.2B—27 Apr 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Amgen: Repatha revenue · EVENITY revenue · Prolia revenue · ENBREL revenue · TEZSPIRE revenue · TEPEZZA revenue · BLINCYTO revenue · Otezla revenue · Nplate revenue · UPLIZNA revenue · KRYSTEXXA revenue · IMDELLTRA/IMDYLLTRA revenue · Vectibix revenue · KYPROLIS revenue · Aranesp revenue · XGEVA revenue · United States revenue · ROW revenue · financial statements

Every KPI and segment of AMGN, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.